PLx Pharma (FRA:1D5A) Price-to-Tangible-Book : 0.00 (As of Jun. 12, 2024)

View and export this data going back to 2014. Start your Free Trial

What is PLx Pharma Price-to-Tangible-Book?

As of today (2024-06-12), PLx Pharma's share price is €0.0005. PLx Pharma's Tangible Book per Share of Sep. 2022 for the quarter that ended in Sep. 2022 was €0.29. Hence, PLx Pharma's Price to Tangible Book Ratio of today is 0.00.

The historical rank and industry rank for PLx Pharma's Price-to-Tangible-Book or its related term are showing as below:

FRA:1D5A's Price-to-Tangible-Book is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.305
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, PLx Pharma's share price is €0.0005. PLx Pharma's Book Value per Sharefor the quarter that ended in Sep. 2022 was €0.37. Hence, PLx Pharma's P/B Ratio of today is 0.00.

PLx Pharma Price-to-Tangible-Book Historical Data

The historical data trend for PLx Pharma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PLx Pharma Price-to-Tangible-Book Chart

PLx Pharma Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Price-to-Tangible-Book

Get a 7-Day Free Trial

21.98

2.70

6.20

PLx Pharma Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Price-to-Tangible-Book	Get a 7-Day Free Trial															19.28	6.20	4.54	4.62	-

Competitive Comparison of PLx Pharma's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, PLx Pharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PLx Pharma's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PLx Pharma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where PLx Pharma's Price-to-Tangible-Book falls into.

PLx Pharma Price-to-Tangible-Book Calculation

PLx Pharma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2022 )
	=	0.0005	/	0.291
	=	0.00

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

PLx Pharma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of PLx Pharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

PLx Pharma (FRA:1D5A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PLx Pharma Inc (FRA:1D5A) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 The Green, Suite 11895, Dover, DE, USA, 19901

Website

https://www.plxpharma.com

PLx Pharma Winddown Corp Formerly PLx Pharma Inc is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard drug delivery platform designed to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the GI tract. It believes this platform has the potential to improve the absorption of many drugs currently on the market or in development and to reduce the risk of stomach erosions and ulcers associated with drugs. VAZALORE is a novel formulation of aspirin clinically shown to provide fast, reliable and predictable platelet inhibition for patients with vascular disease and diabetic patients who may be candidates for aspirin therapy.

PLx Pharma (FRA:1D5A) Headlines

No Headlines